Hodgkin Lymphoma - Frontline Therapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
08:07

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on 1L Advanced cHL: What Are the Outcomes in HIV-cHL vs. Non-HIV-cHL?

FEATURING Juan José Del Moral
  • 19 views
  • December 14, 2020
12:29

2nd SOHO Italian Conference

Managing Hodgkin Lymphoma: PET Adapted Strategies, Applying ECHELON-1 Trial Data to the Frontline Setting

FEATURING John Leonard
  • 233 views
  • December 8, 2020
  • 2
21:36

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Newly Diagnosed HL: Is ABVD Chemo Regimen Beneficial for PFS in Early Stage Disease? Can A+AVD Resolve Peripheral Neuropathy in Advanced Stage Disease?

FEATURING David Straus
  • 127 views
  • November 9, 2020
10:07

UChicago Annual Updates from ASH 2019

ASH 2019 Updates on Hodgkin Lymphoma: Frontline Brentuximab + Nivo in Pts > 60 & PET-adapted Nivo + ICE in First Relapse

FEATURING Justin Kline
  • 314 views
  • March 20, 2020
08:20

UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

CAR T-cell for MCL, LOXO-305 Effective in Pretreated B-Cell, Nivo and Brentuximab Looks Effective, Nivo Showed Limited Activity in R/R PTCL

FEATURING Nathan H. Fowler
  • 258 views
  • March 9, 2020
08:39

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Next Questions in Hodgkin Lymphoma: Brentuximab Vedotin/PD-1+AVD as Frontline in Advanced Disease, as Consolidation Therapy, and Other New Drugs

FEATURING Stephen M. Ansell
  • 416 views
  • October 18, 2019
  • 3
13:07

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Advanced Stage Hodgkin Lymphoma: New EvIdence in Induction, Treatment Intensification in PET2+ Disease, 1st Salvage Settings - Brentuximab w/ or w/o Chemo Regimens, Brentuximab + anti-PD-1

FEATURING Pier Luigi Zinzani
  • 405 views
  • October 18, 2019
  • 2
15:29

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

How I Treat Early Stage Hodgkin Lymphoma: Early Stage Favorable Chemo vs. PET-Adapted Rx, Unfavorable PET-Adapted /RATHL

FEATURING Andrew Evens
  • 413 views
  • October 18, 2019
  • 5
11:13

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Treating Elderly Patients with Hodgkin Lymphoma - How Much Bleomycin Is Too Much and the Frontline Brentuximab Vedotin Options

FEATURING Alison Moskowitz
  • 185 views
  • October 17, 2019
  • 1
39:10

ESO Lymphoma Course

Hodgkin Lymphoma - Kairos vs. Chronos Principle & New Active Agents (Antibody-Drug Conjugates and Checkpoint Antibodies)

FEATURING Peter Johnson
  • 77 views
  • August 19, 2019
27:01

University of Miami Sylvester Comprehensive Cancer Center

Hodgkin Lymphoma - Metabolic Tumor Volume as Prognostic Factor, Role of Radiotherapy, BV + AVD Study and Nivolumab Study

FEATURING Craig Moskowitz
  • 269 views
  • November 19, 2018
14:48

2018 Pan Pacific Lymphoma Conference

Hodgkin Lymphoma German Hodgkin Study Group Upfront Therapy

FEATURING Andreas Engert
  • 31 views
  • October 2, 2018
20:26

2018 Pan Pacific Lymphoma Conference

Radiation Therapy for nondular lymphocyte predominant Hodgkin Lymphoma

FEATURING Richard Hoppe
  • 29 views
  • August 15, 2018
12:32

Indy Hematology Review

Emerging Strategies and Treatment in Hodgkin Lymphoma

FEATURING Bruce Cheson
  • 355 views
  • April 12, 2018
  • 1

Hodgkin Lymphoma - Frontline Therapy

No subtopics